Mizutani Satoshi, Taniai Nobuhiko, Sukegawa Makoto, Haruna Takahiro, Furuki Hiroyasu, Takata Hideyuki, Ueda Junji, Yoshioka Masato, Aimoto Takayuki, Sakamoto Shunichiro, Suzuki Kenji, Nakamura Yoshiharu, Yoshida Hiroshi
Digestive Surgery, Nippon Medical School Musashikosugi Hospital, 1-383 Kosugimachi, Nakahara, Kawasaki 211-8533, Kanagawa, Japan.
Department of Cardiovascular Surgery, Nippon Medical School Musashikosugi Hospital, 1-383 Kosugimachi, Nakahara, Kawasaki 211-8533, Kanagawa, Japan.
Cancers (Basel). 2024 Dec 8;16(23):4115. doi: 10.3390/cancers16234115.
With the advent of effective chemotherapy, conversion surgery (CS) has been performed in patients who have responded to pretreatment, even for pancreatic cancer diagnosed as unresectable (UR) at the time of initial diagnosis. In CS, major arterial resection and reconstruction are necessary for complete radical resection.
We discuss the key points for safely performing pancreatectomy with celiac axis (CA) resection combined with reconstruction, divided into resection and arterial reconstruction. The possibility of safe pancreatectomy concurrent with CA resection and reconstruction depends on the ability to create a "golden view" that provides an unimpaired view of the Abdominal Aorta, CA, Superior Mesenteric Artery, Inferior Vena Cava, and left renal vein from the ventral side. Pancreatectomy concurrent with CA resection requires arterial reconstruction. Postoperatively, arterial blood flow must be maintained. To achieve this, tension-free and short bypass should be observed.
From 2014 to 2024, sixteen URLA patients underwent CS, requiring major artery en bloc resection after pretreatment. We performed DP-CAR in eight patients, gastrectomy-distal pancreatectomy-splenectomy (Appleby procedure) procedure in one patient, PD-CHAR in two patients, PD-CAR in two patients, TP-CAR(spleen preserving) in one patient, and TP-CAR+TG in two patients. In total, five patients required surgery with CA reconstruction. Histopathologically, four of the five patients had T4 pancreatic cancer. The R0 surgical rate was 80%. Complication of Clavien-Dindo IIIa or higher was observed in one patient. There were no deaths.
Parallel to the determination of pretreatment, surgeons must be prepared to safely and reliably perform pancreatectomies that require concurrent major arterial resection and reconstruction.
随着有效化疗方法的出现,对于经预处理后有反应的患者,甚至是初诊时被诊断为不可切除(UR)的胰腺癌患者,也可进行转化手术(CS)。在转化手术中,为实现完整的根治性切除,需要进行主要动脉的切除与重建。
我们讨论了安全实施联合腹腔干(CA)切除与重建的胰腺切除术的关键点,分为切除和动脉重建两部分。能否安全地同时进行胰腺切除术与CA切除和重建,取决于能否创造出一个“黄金视野”,即从腹侧能清晰看到腹主动脉、CA、肠系膜上动脉、下腔静脉和左肾静脉且视野不受阻碍。同时进行CA切除的胰腺切除术需要进行动脉重建。术后必须维持动脉血流。为此,应注意无张力且短的旁路。
2014年至2024年,16例URLA患者接受了转化手术,预处理后需要进行主要动脉整块切除。我们对8例患者实施了保留幽门的胰十二指肠切除术(DP-CAR),1例患者实施了胃切除术-远端胰腺切除术-脾切除术(Appleby手术),2例患者实施了保留幽门的胰十二指肠切除术联合CA切除重建(PD-CHAR),2例患者实施了胰十二指肠切除术联合CA切除(PD-CAR),1例患者实施了保留脾脏的全胰切除术联合CA切除(TP-CAR[保留脾脏]),2例患者实施了全胰切除术联合CA切除及全胃切除术(TP-CAR+TG)。总共有5例患者需要进行CA重建手术。组织病理学检查显示,5例患者中有4例为T4期胰腺癌。R0手术切除率为80%。1例患者出现了Clavien-Dindo IIIa级或更高等级的并发症。无死亡病例。
在确定预处理方案的同时,外科医生必须做好准备,安全、可靠地实施需要同时进行主要动脉切除与重建的胰腺切除术。